NEW YORK (GenomeWeb) – Illumina today launched the NextSeq 550Dx, a US Food and Drug Administration-regulated next-generation sequencer, and said that it has expanded the intended use for the existing MiSeq Dx platform to include formalin-fixed paraffin-embedded tissues.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.